A Novel Gene Expression Scoring System Predicts Recurrence in Non‐Muscle‐Invasive Bladder Cancer Patients
A novel gene expression scoring system was shown to predict recurrence in NMIBC patients after TURBT and might be helpful in clinical decision-making for NMIBC patients.
Authors
- Shinya Watanabe (ORCID: https://orcid.org/0000-0002-9953-8665)
- Tomoyuki Koguchi (ORCID: https://orcid.org/0009-0001-9045-9426)
- Emina Kayama (ORCID: https://orcid.org/0009-0004-6647-1945)
- Hidenori Akaihata
- Satoru Meguro (ORCID: https://orcid.org/0000-0003-2179-5028)
- Soichiro Ogawa (ORCID: https://orcid.org/0000-0001-6002-7879)
- Kei Yaginuma (ORCID: https://orcid.org/0009-0004-1616-3266)
- Akifumi Onagi (ORCID: https://orcid.org/0000-0002-4906-2558)
- Kanako Matsuoka (ORCID: https://orcid.org/0000-0002-0731-4577)
- Junya Hata (ORCID: https://orcid.org/0000-0002-7912-5468)
- Seiji Hoshi (ORCID: https://orcid.org/0000-0003-1545-1827)
- Yuichi Sato (ORCID: https://orcid.org/0000-0002-4441-0306)
- Yoshiyuki Kojima (ORCID: https://orcid.org/0000-0001-8000-0868)
- Motohide Uemura (ORCID: https://orcid.org/0000-0001-7263-7965)
- Reiko Honma
Institutions
- Fukushima Medical University (JP)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2024-11-01
- DOI
- https://doi.org/10.1002/cam4.70349
- Citations
- 1
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.57